Effects of intrathecal baclofen on chronic spinal cord injury pain

Journal of Pain and Symptom Management

Volumn 12, Issue 4, 1996, Pages 241-247

  Loubser, Paul G ^a,b   Akman, Nafiz M ^a,c  

^a Institute for Rehabilitation and Research   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Dept of Phys Med and Rehab   (Turkey)

Author keywords

Chronic pain; intrathecal baclofen; spinal cord injury

Indexed keywords

BACLOFEN;

ADULT; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CONTINUOUS INFUSION; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; IMPLANTATION; INFUSION PUMP; INTRATHECAL DRUG ADMINISTRATION; MALE; QUALITY OF LIFE; SPASTICITY; SPINAL CORD INJURY;

EID: 0030271401     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/0885-3924(96)00152-2     Document Type: Article

References (29)

1. 1. Burke DC, Woodward JM. Pain and phantom sensation in spinal paralysis. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology, vol 26. Amsterdam: North-Holland, 1976:489-499.
2. 2. Penn RD, Kroin JS. Continuous intrathecal baclofen for severe spasticity. Lancet 1985;2:125-127.
3. 3. Penn RD, Kroin JS. Long term intrathecal baclofen infusion for treatment of spasticity. J Neurosurg 1987;66:181-185.
4. 4. Albright AL, Barron WB, Fasick MP, Polinko P, Janosky J. Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA 1993;270: 2475-2477.
5. 5. Muller H, Zierski J, Borner U, Hempelmann G. Intrathecal baclofen in tetanus. Ann NY Acad Sci 1988;531:167-173.
6. 6. Rifici C, Kofler M, Fromberg M, Kofler A, Bramanti P, Saltuari, L. Intrathecal baclofen application in patients with supraspinal spasticity secondary to severe traumatic brain injury. Funct Neurol 1994;1:29-34.
7. 7. Narayan RK, Loubser PG, Jankovic J, Donovan WH, Bontke CF. Intrathecal baclofen for intractable axial dystonia. Neurology 1991;41:1141-1142.
8. 8. Parke B, Penn RD, Savoy SM, Corcos D. Functional outcome after delivery of intrathecal baclofen. Arch Phys Med Rehabil 1989;70:30-32.
9. 9. Broseta J, Morales F, Garcia-March G, et al. Use of intrathecal baclofen administered by programmable infusion pumps in resident spasticity. Acta Neurochirurgica Suppl (Wien) 1989;46:39-45.
10. 10. Loubser PG, Narayan RK, Sandin KJ, Donovan WH, Russell RD. Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury. Paraplegia 1991;29:48-64.
11. 11. Taira T, Tanikawa T, Kawamura H, Ikeki H, Takakura K. Spinal intrathecal baclofen suppresses central pain after a stroke [Letter]. J Neurol Neurosurg Psychiatry 1994;57:381-382.
12. 12. Herman RM, Luzanksy SC, Ippolito R. Intrathecal baclofen suppresses central pain in patients with spinal lesions. Clin J Pain 1992;8:338-345.
13. 13. Muller H, Zierski J, Dralle D, Krau D, Mutschier E. Pharmacokinetics of intrathecal baclofen. In: Muller H, Zierski J, Penn RD, eds. Local-spinal therapy of spasticity. Berlin: Springer-Verlag, 1988: 223-226.
14. 14. Merskey H, Bogduk N. Pain terms-a current list with definitions and notes on usage. In: Merskey H, Bogduk N, eds. Classification of chronic pain syndromes and definitions of pain terms. Seattle: IASP, 1994:209-213.
15. 15. Beric A. Altered sensation and pain in spinal cord injury. In: Dimitrijevic MR, Wall PD, Lindblom U, eds. Recent Achievements in Restorative Nuerology. London: Karger, 1990:27-36.
16. 16. Beric A, Dimitrijevic MR, Light K. A clinical syndrome of rostral and caudal spinal injury. J Neurol Neurosurg Psychiatry 1987;50:600-606.
17. 17. Beric A, Dimitrijevic MR, Lindblom U. Central dysesthesia syndrome in spinal cord injury patients. Pain 1988;34:109-116.
18. 18. Donovan WH, Dimitrijevic MR, Dahm L, Dimitrijevic M. Neurophysiologic approaches to chronic pain following spinal cord injury. Paraplegia 1982; 20:135-146.
19. 19. Sjoberg M, Appelgren L, Einarsson S, et al. Long-term intrathecal morphine and bupivacaine in "refractory" cancer pain. I. Results of the first series of 52 patients. Acta Anaesthesiol Scand 1991; 35:30-43.
20. 20. Goodman RR, Brisman R. Treatment of lower extremity reflex sympathetic dystrophy with continuous intrathecal morphine infusion. Appl Neurophysiol 1987;50:425-426.
21. 21. Siddall PJ, Gray M. Rutkowski S, Cousins MJ. Intrathecal morphine and clonidine in the management of spinal cord injury pain: a case report. Pain 1994;59:147-148.
22. 22. Glynn H, Teddy P. Assessment and management of the patient with spinal cord injury and pain. In: Alderson JD, Frost EAM, eds. Spinal cord injuries, anaesthetic and associated care. Boston: Butterworths, 1990:139-165.
23. 23. Glynn CJ, Jamous MA, Teddy PJ, Moore RA, Lloyd JW. Role of spinal noradrenergic system in transmission of pain in patients with spinal cord injury. Lancet 1986;2:1249-1250.
24. 24. Sawynok J. GABAergic mechanisms of analgesia: an update. Pharm Biochem Behav 1987; 26:463-474.
25. 25. Basbaum AI. Functional analysis of the cytochemistry of the spinal cord. In: Fields HL, Dubner R, Cervero F, eds. Advances in pain research and therapy, vol 9. New York: Raven, 1985: 149-175.
26. 26. Henry JL. Pharmacologic studies on the prolonged depressant effects of baclofen on lumbar dorsal horn units in the cat. Neuropharmacology 1982:21:1085-1093.
27. 27. Yaksh TL. Behavioral and autonomie correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists. Pain 1989:37:111-123.
28. 28. Hao JX, Hu XJ, Aldskogius H, Seiger A, Wiesenfeld-Hallin Z. Allodynia-like effects in rats after ischemic spinal cord injury phytochemically induced by laser irradiation. Pain 1991;45:175-185.
29. 29. Fromm GH, Terrence CF, Chattha AS. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol 1984;15:240-244.